iifl-logo-icon 1

Zenlabs Ethica Ltd Share Price

38.5
(-1.61%)
Jul 23, 2024|09:56:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open39.4
  • Day's High39.4
  • 52 Wk High70
  • Prev. Close39.13
  • Day's Low38.3
  • 52 Wk Low31.3
  • Turnover (lac)0.51
  • P/E60.2
  • Face Value10
  • Book Value15.54
  • EPS0.65
  • Mkt. Cap (Cr.)25.06
  • Div. Yield0
No Records Found

Zenlabs Ethica Ltd KEY RATIOS

Sector

Trading

Open

39.4

Prev. Close

39.13

Turnover(Lac.)

0.51

Day's High

39.4

Day's Low

38.3

52 Week's High

70

52 Week's Low

31.3

Book Value

15.54

Face Value

10

Mkt Cap (₹ Cr.)

25.06

P/E

60.2

EPS

0.65

Divi. Yield

0

Zenlabs Ethica Ltd Corporate Action

10 Jun 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

4 Sep 2023

12:00 AM

AGM

Announcement Date: 04 Sep, 2023

arrow

Zenlabs Ethica Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Zenlabs Ethica Ltd SHAREHOLDING SNAPSHOT

23 Jul, 2024|10:09 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 52.96%

Foreign: 0.00%

Indian: 52.96%

Non-Promoter- 47.03%

Institutions: 0.00%

Non-Institutions: 47.03%

Custodian: 0.00%

Share Price

Zenlabs Ethica Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

6.51

6.51

6.51

6.51

Preference Capital

0

0

0

0

Reserves

3.19

2.82

2.05

0.9

Net Worth

9.7

9.33

8.56

7.41

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

56.64

59.94

71.83

81.15

yoy growth (%)

-5.52

-16.54

-11.48

415.22

Raw materials

-46.72

-49.45

-57.11

-65.41

As % of sales

82.49

82.5

79.5

80.6

Employee costs

-3.35

-3.97

-2.8

-3.05

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

0.92

-1.16

1.65

1.22

Depreciation

-0.27

-0.29

-0.2

-0.2

Tax paid

-0.09

0.43

-0.48

-0.27

Working capital

0.39

0.42

1.51

1.49

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-5.52

-16.54

-11.48

415.22

Op profit growth

-230.72

-145.92

27.25

629.77

EBIT growth

-188.2

-162.5

31.24

237.93

Net profit growth

-213.53

-162.95

22.29

459

View Ratios

No Record found

Zenlabs Ethica Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Adani Enterprises Ltd

ADANIENT

3,000.15

122.463,42,017.44776.710.049,210.18145.96

Aegis Logistics Ltd

AEGISLOG

844.95

73.0929,657.75125.880.38721.5167.87

Cello World Ltd

CELLO

948.55

339.9820,952.0518.620.15260.7765.65

Redington Ltd

REDINGTON

202.4

15.2115,823.11160.573.0610,490.2446.35

Honasa Consumer Ltd

HONASA

463.4

124.2415,025.4726.710427.1734.67

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Zenlabs Ethica Ltd

Management

Register Office

Registrar Office

Managing Director & CEO

Sanjeev Kumar

Director

Him Jyoti

Independent Director

Ashok Kumar Gupta

Whole Time Director & CFO

Sanjay Dhir

Independent Director

Anurag Malhotra

Director

Kuldeep Singh

Executive Director

HITESH POPATLAL OSWAL

Company Sec. & Compli. Officer

Akshay Saxena

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993. The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network. It deals into marketing and distribution of pharmaceutical products and has grown to be of Indias top pharmaceutical companies in 2019.The Company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada. The strength lies in quality, affordable and branded drugs in enhancing the quality of life of people. Apart from this, it offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.In 2023, the Company has ventured into diversified segments like Neurology and Cytrics. It manufactures drugs for varied brands and sticks to international standards and prescribed norms. These drugs are marketed in factory packaging. As a WHO GMP certified company, the quality of each product is of highly advanced procurement & supply facility.
Read More

Company FAQs

What is the Zenlabs Ethica Ltd share price today?

Down Arrow

The Zenlabs Ethica Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹38.5 today.

What is the Market Cap of Zenlabs Ethica Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Zenlabs Ethica Ltd is ₹25.06 Cr. as of 23 Jul ‘24

What is the PE and PB ratio of Zenlabs Ethica Ltd?

Down Arrow

The PE and PB ratios of Zenlabs Ethica Ltd is 60.2 and 2.52 as of 23 Jul ‘24

What is the 52 Week High and Low of Zenlabs Ethica Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Zenlabs Ethica Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Zenlabs Ethica Ltd is ₹31.3 and ₹70 as of 23 Jul ‘24

What is the CAGR of Zenlabs Ethica Ltd?

Down Arrow

Zenlabs Ethica Ltd's CAGR for 5 Years at 3.22%, 3 Years at -1.58%, 1 Year at 9.85%, 6 Month at -32.78%, 3 Month at -5.69% and 1 Month at -6.83%.

What is the shareholding pattern of Zenlabs Ethica Ltd?

Down Arrow

The shareholding pattern of Zenlabs Ethica Ltd is as follows:
Promoters - 52.96 %
Institutions - 0.00 %
Public - 47.04 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.